Julie Angileri
Psychiatric/Mental Health · Mesa, AZNPI 1235515768
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (45.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Takeda Pharmaceuticals U.S.A., Inc. accounts for 68.1% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2022 at $4,800 and has fallen 95.0% since, to $238 in 2025. Among psychiatric/mental health clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 90 payments — averaging $68.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$4K
- Otsuka America Pharmaceutical, Inc.$542
- Lundbeck LLC$292
- Corium, LLC$259
- AbbVie$214
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$207
- plus $442 from 8 others
What the payments were for
- Consulting fees$2,80546%
- Travel & lodging$99416%
- Food & beverage$2,27737%
- Education$491%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $4,171 |
| Otsuka America Pharmaceutical, Inc. | 23 | $542 |
| Lundbeck LLC | 13 | $292 |
| Corium, LLC | 8 | $259 |
| AbbVie | 13 | $214 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $207 |
| Alkermes, Inc. | 2 | $123 |
| Amgen | 1 | $116 |
| Vanda Pharmaceuticals Inc. | 3 | $55 |
| Ironshore Pharmaceuticals Inc. | 3 | $53 |
| Tris Pharma Inc | 2 | $34 |
| Johnson & Johnson | 1 | $33 |
| Eisai Inc. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRINTELLIX$3,834
- Azstarys$122
- KRYSTEXXA$116
- REXULTI$108
How this compares
$6,126 in reported general payments places this provider in the 95th percentile of 1,230 psychiatric/mental health providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atomoxetine Hcl | 30 | $1,152 |
| Bupropion XlBupropion Hcl | 36 | $1,142 |
| Aripiprazole | 51 | $911 |
| Lurasidone Hcl | 11 | $808 |
| Lamotrigine | 49 | $792 |
| Quetiapine Fumarate | 68 | $775 |
| Buspirone Hcl | 43 | $542 |
| Sertraline Hcl | 75 | $535 |
| Bupropion Hcl SrBupropion Hcl | 39 | $535 |
| Duloxetine Hcl | 21 | $477 |
| Fluvoxamine Maleate | 19 | $470 |
| Trazodone Hcl | 32 | $244 |
| Fluoxetine Hcl | 27 | $227 |
| Mirtazapine | 14 | $222 |
| Escitalopram Oxalate | 19 | $155 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Mesa
- Stacy UnderwoodMesa$252K
- Jesika McKenzieMesa$36K
- Gail ZivMesa$29K
- Rebecca DepalmaMesa$19K
- Richard BealsMesa$10K
- Troy FultonMesa$9K
- Joan ButlerMesa$8K
- Ana WilliamsMesa$6K
- Elizabeth ElliottPhoenix$363K
- Diane StrickerGilbert$281K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.